BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 6379804)

  • 1. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum and bone marrow acid phosphatase.
    Pontes JE
    Prostate; 1980; 1(4):465-70. PubMed ID: 7024959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
    Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
    Trans Am Assoc Genitourin Surg; 1979; 71():26-30. PubMed ID: 545810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tests for prostate-derived enzymes. B. Immunochemical analysis of serum PAP and its clinical significance].
    Koiso K; Nemoto R; Ishikawa S; Uchida K
    Rinsho Byori; 1986 Jul; 34 Spec No 68():42-9. PubMed ID: 3531635
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prostatic acid phosphatase (PAP): monoclonal enzyme-linked immunoassay compared to polyclonal radioimmunoassay.
    Taylor EH; Gadsden RH
    Ann Clin Lab Sci; 1984; 14(1):21-6. PubMed ID: 6364952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
    Zweig MH; Ihde DC
    Cancer Res; 1985 Aug; 45(8):3945-50. PubMed ID: 3893691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in prostate cancer].
    Kuriyama M
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of immunoenzyme assay for prostatic acid phosphatase].
    Yoshida K; Sato S; Nishimura T; Akimoto M
    Hinyokika Kiyo; 1989 Oct; 35(10):1819-22. PubMed ID: 2692448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases].
    Guerin JL; Canal P; Douchez J; Soula G
    Bull Cancer; 1989; 76(10):1077-82. PubMed ID: 2635635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphatase.
    Killian CS; Vargas FP; Lee CL; Wang MC; Murphy GP; Chu TM
    Invest Urol; 1980 Nov; 18(3):219-24. PubMed ID: 7429782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.